Page last updated: 2024-10-22

apraclonidine and Chronic Disease

apraclonidine has been researched along with Chronic Disease in 6 studies

apraclonidine: relieves postoperative intraocular pressure following trabeculoplasty; RN given refers to parent cpd
apraclonidine : An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Intraocular pressure was measured by a masked observer, using Goldmann applanation tonometry, before and 1 hour after the treatment."6.69Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. ( Assalian, A; Chevrier, RL; Duperré, J; Lesk, MR, 1999)
"Apraclonidine 1."6.69Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma. ( Chang, FW; Kolin, T; Nishimoto, JH; Tang, IH, 1999)
"2% topical medication or the replacement of apraclonidine with brimonidine resulted in a significant decrease in mean intraocular pressure from 20."5.09Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy. ( Cha, SC; Glover, BK; Kim, C; Kim, YY; Nguyen, KD; Shin, DH, 1999)
"Apraclonidine effectively lowers IOP associated with open-angle glaucoma or ocular hypertension; these pilot results will need to be confirmed by a larger pivotal study."5.07Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study. ( Chuniaud, M; Demailly, P; Hitchings, RA; Nagasubramanian, S; Pannarale, MR; Parsons, DG; Pecori-Giraldi, J; Stodtmeister, R, 1993)
"Intraocular pressure was measured by a masked observer, using Goldmann applanation tonometry, before and 1 hour after the treatment."2.69Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. ( Assalian, A; Chevrier, RL; Duperré, J; Lesk, MR, 1999)
"Apraclonidine 1."2.69Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma. ( Chang, FW; Kolin, T; Nishimoto, JH; Tang, IH, 1999)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagasubramanian, S1
Hitchings, RA1
Demailly, P1
Chuniaud, M1
Pannarale, MR1
Pecori-Giraldi, J1
Stodtmeister, R1
Parsons, DG1
Gross, RL1
Pinyero, A1
Orengo-Nania, S1
Lamberti, G1
Pignalosa, B1
Fusco, R1
Pignalosa, G1
Di Govanni, A1
Sebastiani, A1
Chevrier, RL1
Assalian, A1
Duperré, J1
Lesk, MR1
Shin, DH1
Glover, BK1
Cha, SC1
Kim, YY1
Kim, C1
Nguyen, KD1
Nishimoto, JH1
Chang, FW1
Tang, IH1
Kolin, T1

Trials

5 trials available for apraclonidine and Chronic Disease

ArticleYear
Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study.
    Ophthalmology, 1993, Volume: 100, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Clonidine; Double-Blind Method; Drug Administration

1993
Short-term clinical trial evaluating the efficacy of the combination of apraclonidine 0.5% solution and betaxolol 0.25% suspension.
    Acta ophthalmologica Scandinavica. Supplement, 1997, Issue:224

    Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Chronic

1997
Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:3

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Brimonidine Tartrat

1999
Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.
    American journal of ophthalmology, 1999, Volume: 127, Issue:5

    Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Chronic Disease; Clonidine; Drug Hypersensiti

1999
Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Journal of the American Optometric Association, 1999, Volume: 70, Issue:4

    Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Chronic Disease; Clonidine; Double-Blind Method;

1999

Other Studies

1 other study available for apraclonidine and Chronic Disease

ArticleYear
Clinical experience with apraclonidine 0.5%.
    Journal of glaucoma, 1997, Volume: 6, Issue:5

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Cloni

1997